Anchalee Avihingsanon Selected Research

efavirenz (Sustiva)

1/2020	Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand.
1/2016	Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anchalee Avihingsanon Research Topics

Disease

33	Coinfection 03/2024 - 01/2008
27	Infections 05/2024 - 04/2009
18	Tuberculosis (Tuberculoses) 04/2024 - 01/2008
15	HIV Infections (HIV Infection) 03/2023 - 03/2003
13	Fibrosis (Cirrhosis) 03/2024 - 09/2008
12	Acquired Immunodeficiency Syndrome (AIDS) 03/2023 - 01/2011
11	Hepatitis B 10/2023 - 09/2008
10	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 09/2008
10	Viremia 01/2022 - 04/2012
8	Liver Diseases (Liver Disease) 03/2024 - 09/2008
6	Body Weight (Weight, Body) 01/2023 - 04/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2020
5	Hypertension (High Blood Pressure) 07/2023 - 04/2016
5	Hepatitis C 01/2022 - 09/2014
4	Diabetes Mellitus 12/2022 - 01/2017
4	Chronic Hepatitis B 06/2021 - 01/2010
4	Chronic Renal Insufficiency 12/2020 - 09/2012
4	Lipodystrophy 01/2017 - 03/2003
3	Chronic Hepatitis C 05/2024 - 01/2021
3	Anemia 01/2024 - 01/2017
3	Syphilis 01/2022 - 01/2020
3	Opportunistic Infections (Opportunistic Infection) 09/2019 - 01/2015
2	Virus Diseases (Viral Diseases) 05/2024 - 01/2022
2	Inflammation (Inflammations) 03/2024 - 01/2021
2	Cognitive Dysfunction 12/2023 - 01/2019
2	Immune Reconstitution Inflammatory Syndrome 10/2023 - 11/2009
2	Dyslipidemias (Dyslipidemia) 07/2023 - 03/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 01/2019
2	Frailty 12/2022 - 01/2022
2	Weight Gain 11/2022 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2013
2	Latent Tuberculosis 01/2021 - 03/2012
2	Insulin Resistance 01/2015 - 03/2003
1	Granuloma 04/2024
1	Cryptococcal Meningitis 10/2023
1	Non-alcoholic Fatty Liver Disease 07/2023
1	Arteriosclerosis 07/2023
1	Pulmonary Tuberculosis 03/2023

Drug/Important Bio-Agent (IBA)

17	Tenofovir (Viread)FDA Link 10/2023 - 04/2009
14	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2008
11	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 09/2008
8	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2020
8	Ritonavir (Norvir)FDA Link 12/2022 - 10/2012
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2009
6	Hepatitis B e AntigensIBA 06/2021 - 09/2008
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2023 - 01/2020
5	Alanine Transaminase (SGPT)IBA 11/2022 - 09/2008
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 03/2007
4	tenofovir alafenamideIBA 12/2023 - 01/2021
4	Emtricitabine (Emtriva)FDA Link 10/2023 - 01/2010
4	Isoniazid (Ftivazide)FDA LinkGeneric 09/2023 - 03/2012
4	Rifampin (Rifampicin)FDA LinkGeneric 03/2023 - 01/2008
4	Lopinavir FDA Link 12/2022 - 01/2016
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022 - 01/2013
4	AntigensIBA 01/2022 - 08/2009
4	InterferonsIBA 06/2021 - 09/2014
3	EnzymesIBA 04/2024 - 09/2014
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 07/2013
3	Stavudine (Zerit)FDA LinkGeneric 07/2023 - 03/2007
3	Reverse Transcriptase InhibitorsIBA 01/2022 - 04/2009
3	elbasvirIBA 10/2021 - 01/2020
3	grazoprevirIBA 10/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
3	N-acetyltalosaminuronic acid (NAT)IBA 09/2020 - 01/2016
2	SofosbuvirIBA 05/2024 - 01/2021
2	ravidasvirIBA 05/2024 - 01/2021
2	HMGB1 Protein (HMG1)IBA 03/2024 - 01/2023
2	dolutegravirIBA 10/2023 - 01/2021
2	Didanosine (Videx)FDA LinkGeneric 07/2023 - 01/2017
2	CalciumIBA 07/2023 - 01/2022
2	LipidsIBA 01/2023 - 03/2007
2	Interleukin-6 (Interleukin 6)IBA 12/2022 - 09/2014
2	CreatinineIBA 01/2022 - 04/2016
2	RacivirIBA 01/2021 - 01/2010
2	Lipopolysaccharide ReceptorsIBA 09/2020 - 09/2014
2	efavirenz (Sustiva)FDA Link 01/2020 - 01/2016
2	HDL CholesterolIBA 01/2019 - 01/2013
2	Raltegravir Potassium FDA Link 11/2017 - 04/2012
2	Atazanavir Sulfate (Reyataz)FDA Link 05/2015 - 12/2013
2	Nevirapine (Viramune)FDA Link 09/2014 - 01/2008
2	Vitamin D FDA LinkGeneric 09/2014 - 01/2014
2	Lamivudine (Epivir)FDA Link 03/2012 - 01/2010
1	Tryptophan (L-Tryptophan)FDA Link 04/2024
1	KynurenineIBA 04/2024
1	bictegravirIBA 10/2023
1	Zidovudine (Retrovir)FDA LinkGeneric 07/2023
1	Nucleic AcidsIBA 07/2023
1	trans-crotonin (CTN)IBA 07/2023
1	TroponinIBA 07/2023
1	bedaquiline (R207910)IBA 03/2023
1	Linezolid (Zyvox)FDA Link 03/2023
1	Ethambutol (Myambutol)FDA LinkGeneric 03/2023
1	Pyrazinamide FDA LinkGeneric 03/2023

Therapy/Procedure

37	Therapeutics 04/2024 - 03/2007
25	Art Therapy 03/2024 - 11/2009
12	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 03/2007
2	Aftercare (After-Treatment) 03/2023 - 03/2007
2	Polypharmacy 01/2022 - 01/2019
1	Duration of Therapy 12/2023
1	Retreatment 03/2023